HOTFy: ensaio clínico randomizado sobre a eficácia da oxigenoterapia hiperbárica no tratamento da fibromialgia e análise de custo-efetividade da tecnologia
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Introduction: Fibromyalgia is a chronic condition characterised by widespread
musculoskeletal pain and associated multisystem symptoms, including fatigue,
sleep disturbances, and neuropsychiatric manifestations. It affects approximately
2.5% of the Brazilian population and significantly impacts functional capacity,
work productivity, and healthcare utilisation. Although multimodal management is
the current standard of care, many patients experience persistent symptoms,
warranting investigation of adjunctive interventions such as hyperbaric oxygen
therapy (OHB). OHB may modulate inflammatory and immunological pathways
involved in fibromyalgia-associated neuroinflammation, and its economic value
also warrants evaluation. Objectives: To evaluate the clinical impact of OHB on
somatic and neuropsychiatric symptoms of fibromyalgia and to assess its
economic feasibility as an adjunctive therapeutic strategy. Methods: This study,
approved by a Research Ethics Committee and registered in the Brazilian
Registry of Clinical Trials, integrated clinical outcomes from the HOTFy
randomised clinical trial into a cost-effectiveness analysis. Standard multimodal
treatment alone was compared with standard treatment combined with OHB in
56 participants with fibromyalgia. Assessments conducted at weeks 8 and 16
employed validated instruments to measure disease impact (FIQR-Br),
psychopathological symptoms (EAS-40), and health-related quality of life (SF12), alongside appropriate statistical analyses and deterministic, univariate
sensitivity analyses. Results: The addition of OHB to standard treatment resulted
in statistically significant and clinically meaningful improvements in functional and
symptomatic outcomes, as well as a reduction in the overall impact of
fibromyalgia. Exploratory analyses suggested greater benefit when the
intervention was initiated earlier. The economic evaluation demonstrated a
favourable incremental cost-effectiveness ratio, remaining below the acceptability
thresholds adopted in Brazil. Conclusions: Hyperbaric oxygen therapy was a
clinically effective and cost-effective adjunct for treating fibromyalgia, supporting
its consideration for inclusion in multimodal therapeutic strategies within
healthcare systems.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

